Pentabamate

This classification denotes an antipsychotic agent with the molecular formula C8H16N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8871ZB4UGC, chemically known as 1,2,3-trimethyltrimethylenedicarbamate but generally known as pentabamate, which bears US NIH Compound Identifier 3047822. European Medicines Agency schedules Pentabamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09674MIG. The term PENTABAMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). PENTABAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentabamate under HS 29241900 and SITC 51471. As of Q4 2014, PENTABAMATE remains the US FDA Preferred Term for this commodity. Pentabamate bears US NLM identifiers UMLS ID C2347464 and NCI Concept Code C74165. SMILES: O(C(C(C(OC(=O)N)C)C)C)C(=O)N.